Skip to main content
About
Case Studies
Testimonials
Board members
Investors
Management team
Contact us
Services
Offerings
Protein Science
X-ray crystallography
Assay Development
Biophysics
Biochemistry
Synthetic Chemistry
Virtual screening
Screening
Computational Chemistry
Medicinal Chemistry
Cell Biology
ADME and Bioanalytical Sciences
Analytical Sciences
Research Phases
Hit Identification
Hit to Lead
Lead Optimisation
Therapeutic Areas
Oncology
Immuno-Oncology
Cardiovascular
Respiratory
Anti-infectives
Inflammatory diseases
Target Classes
Kinases
GPCRs
Proteases
Methyltransferases
Ion Channels
Protein-Protein Interactions
Approaches
CDH (Target Gene Fragmentation)
PoLiPa (Membrane Protein Solubilisation)
LeadBuilder
FragmentBuilder
Fragment Based Drug Design (FBDD)
Structure Based Drug Design (SBDD)
Library
Brochures
Posters
Presentations
Publications
White Papers
News & Events
Careers
Search
Enquire
News & Events
Breadcrumb
Home
News & Events
News
How can Domainex enrich your medicines pipeline?
14 Sep '20
Blog Post
Invivoscribe Launches New Division for Drug Development. Licenses Small Molecule Inhibitors from Domainex to Treat Acute Myeloid Leukemia.
14 Jul '20
Press Release
Domainex announces the appointment of Dr. Eddy Littler as non-executive Chairman
2 Jun '20
Press Release
Coronavirus/COVID-19 update
17 Mar '20
News Article
LUNAC Therapeutics selects Domainex as its strategic drug discovery partner
25 Feb '20
Press Release
Domainex announces the appointment of Tom Mander as Chief Executive Officer Cambridge, UK, 13th February 2020 / Domainex Ltd is pleased to announce the appointment of Dr Tom Mander as Chief Executive Officer. Dr Mander will take over when Dr Trevor Perri
13 Feb '20
Press Release
Events
Nov
19
31st Symposium on Medicinal chemistry in Eastern England
Jul
5
Kinase 2021
Aug
28
XXVI EFMC International Symposium on Medicinal Chemistry
Tweets
Tweets by Domainex_UK
Start your next project with Domainex
Contact one of our experts today
